The Tofacitinib study was normal, but it is my understanding that MTX non responders with active RA, often get the monotherapy weekly dose of Humira that is more effective (before switched to other anti-TNF or other class).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.